Medical Condition News

RSS

RXi Pharmaceuticals, TransDerm collaborate on study of RXi's proprietary compounds in dermatology applications

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), and TransDerm, Inc., a biopharmaceutical company developing nucleic acid skin delivery technologies and therapeutics for skin disorders, announced today that they will collaborate on studying the potential utility of RXi's proprietary compounds in dermatology models.

7 Apr 2010

Patients with sickle cell disease require acute care: Study

Patients with sickle cell disease average about 2.5 hospital visits per year, with 18- to 30-year old patients more likely to require acute care or rehospitalization, according to a study in the April 7 issue of JAMA.

7 Apr 2010

Blocking POLQ gene activity can increase ability of radiotherapy to destroy tumours

Cancer Research UK scientists have identified a gene that once blocked could increase the effectiveness of radiotherapy on tumours, according to research published in Cancer Research today (Thursday).

7 Apr 2010

MMRC initiates Phase Ib/II study of Treanda in combination with Revlimid and dexamethasone

The Multiple Myeloma Research Consortium (MMRC) today announced the initiation of a Phase Ib/II study of bendamustine (Treanda®), an anticancer agent currently approved for the treatment of chronic lymphocytic leukemia (CLL) and B-cell non-Hodgkin's lymphoma (NHL), in combination with lenalidomide (Revlimid®) and dexamethasone in patients with relapsed multiple myeloma. The trial, led by Shaji Kumar, MD, of Mayo Clinic, is open for enrollment at Mayo Clinic (Rochester, Minn.), City of Hope Cancer Center (Duarte, Calif.) and the University of Chicago (Chicago, Ill).

7 Apr 2010

Many health care professionals not aware of health problems associated with mouth breathing

For some, the phrase "spring is in the air" is quite literal. When the winter snow melts and flowers bloom, pollen and other materials can wreak havoc on those suffering from seasonal allergies, usually causing a habit called "mouth breathing."

7 Apr 2010

MicuRx Pharmaceuticals, Cumencor Pharmaceuticals, Pfizer collaborate to develop antibiotics for MDR-TB

MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and Cumencor Pharmaceuticals, Inc. today announced that the companies have entered a collaboration with Pfizer to discover novel therapeutic agents to treat multi-drug resistant tuberculosis.

7 Apr 2010

IPS examines malnutrition, obesity in Latin America

Inter Press Service examines malnutrition and factors contributing to the rising rates of "obesity and obesity-related illness - such as type II diabetes, high blood pressure, heart disease, some forms of cancer and osteoporosis - in Latin America, and especially among the poorest sectors of the population."

7 Apr 2010

Children with FASD show high prevalence of developing epilepsy

Children with Fetal Alcohol Spectrum Disorder show a very high prevalence of developing epilepsy and having seizures, according to a national study by Queen's University researchers.

7 Apr 2010

Research shows direct link between dental health and general health

Research has shown a direct link between the health of our mouths and our general health. Periodontal (gum) disease may increase adult risk of diseases such as heart, stroke, diabetes and respiratory diseases. Tooth and gum disease and is one of the most common dental problems of older adults.

7 Apr 2010

CancerGuide Diagnostics, Duke University form cancer research collaboration and licensing agreement

CancerGuide Diagnostics™, Inc. today announced that it has entered into a research collaboration and licensing agreement with Duke University to discover and develop tests to support individualized cancer treatment decisions.

7 Apr 2010

FDA grants "Fast Track" designation for Genta’s advanced gastric cancer drug tesetaxel

Genta Incorporated today announced that the U.S. Food and Drug Administration (FDA) has granted the Company's request for "Fast Track" designation of tesetaxel for treatment of patients with advanced gastric cancer. Tesetaxel -- a late Phase 2 oncology product -- is the leading oral taxane currently in clinical development.

7 Apr 2010

New study shows utility of Chronix Biomedical's serum DNA tests in MS

Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests to predict clinical status and monitor disease activity and response to treatment in multiple sclerosis. Chronix Biomedical uses proprietary technology to identify disease-specific genetic fingerprints based on the circulating DNA that is released into the bloodstream by damaged and dying cells.

6 Apr 2010

Src can be most promising targets for cancer therapy

Src (short for sarcoma) is a family of proto-oncogenic tyrosine kinases active in many cancer tumors, including medulloblastoma, the most common malignant cancer in children. Src represents one of the most promising targets for cancer therapy.

6 Apr 2010

SANUWAVE Health announces completion of patient enrollment in dermaPACE Phase III clinical trial

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, today announced that patient enrollment was completed in March in its dermaPACE™ Phase III pivotal, randomized, double-blinded, sham controlled, multicenter clinical trial comparing its Pulsed Acoustic Cellular Expression technology, utilizing the dermaPACE™ tissue regeneration device, to sham control for the treatment of diabetic foot ulcers.

6 Apr 2010

Policy makers and experts to discuss future challenges in respiratory diseases

This lunchtime seminar entitled "Research and Respiratory Medicine: Addressing future challenges for improved lung health" is being organised by the European Respiratory Society in the context of 2010 the Year of the Lung and under the patronage of Prof. Ioannis A. Tsoukalas MEP and Ms. Satu Hassi MEP.

6 Apr 2010

Health care reform will have negative effect on cardiology patients, practices: American cardiologists

American cardiologists believe that recently passed health care reform will have a negative effect on both their cardiology patients and their practices, according to a new survey.

6 Apr 2010

Messenger substance plays significant role in viral diseases and reactions to infections

The connection with the blood circulatory system is a significant step in the development of cancer. Within the tissue where it is growing, the tumour develops an independent existence. With signal substances it entices white blood cells from the bone marrow into the tumour tissue.

6 Apr 2010

OMA calls for restrictions on the use of artificial tanning equipment

Ontario's doctors are moving to dispel the common misconception that salon tanning beds are safer than the sun. Recently, the Ontario Medical Association adopted a policy calling for restrictions on the use of artificial tanning equipment, so that tanning beds cannot be used by those under 18 years of age.

6 Apr 2010

Oncologists to provide overview on new neuro-oncology guidelines

John Theurer Cancer Center at Hackensack University Medical Center will bring together top neuro-oncologists from around the country for an all day symposium to address new treatment updates and review management of complex cases across a broad array of neuro-oncology specialties.

6 Apr 2010

Electronic nose may help identify asthma in patients: CHEST

New evidence shows that an "electronic nose" containing an array of gas sensors may have the ability to identify asthma in patients. Researchers from Italy compared the diagnostic performance of the electronic nose with lung function tests and fraction of exhaled nitric oxide in seven patients with asthma and seven healthy subjects.

6 Apr 2010

Medical Condition News

RXi Pharmaceuticals, TransDerm collaborate on study of RXi's proprietary compounds in dermatology applications

Patients with sickle cell disease require acute care: Study

Blocking POLQ gene activity can increase ability of radiotherapy to destroy tumours

MMRC initiates Phase Ib/II study of Treanda in combination with Revlimid and dexamethasone

Many health care professionals not aware of health problems associated with mouth breathing

MicuRx Pharmaceuticals, Cumencor Pharmaceuticals, Pfizer collaborate to develop antibiotics for MDR-TB

IPS examines malnutrition, obesity in Latin America

Children with FASD show high prevalence of developing epilepsy

Research shows direct link between dental health and general health

CancerGuide Diagnostics, Duke University form cancer research collaboration and licensing agreement

FDA grants "Fast Track" designation for Genta’s advanced gastric cancer drug tesetaxel

New study shows utility of Chronix Biomedical's serum DNA tests in MS

Src can be most promising targets for cancer therapy

SANUWAVE Health announces completion of patient enrollment in dermaPACE Phase III clinical trial

Policy makers and experts to discuss future challenges in respiratory diseases

Health care reform will have negative effect on cardiology patients, practices: American cardiologists

Messenger substance plays significant role in viral diseases and reactions to infections

OMA calls for restrictions on the use of artificial tanning equipment

Oncologists to provide overview on new neuro-oncology guidelines

Electronic nose may help identify asthma in patients: CHEST

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News